Dalamaga, M. Karampela, I. Mantzoros, C.S., Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19, Metabolism: Clinical and Experimental, (109), 2020, W.B. Saunders, 0026-0495